BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29162879)

  • 21. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
    Yin Y; Cai J; Meng F; Sui C; Jiang Y
    Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
    Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
    Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.
    Zhang G; Liu Z; Xu H; Yang Q
    Biochem Biophys Res Commun; 2016 Jan; 469(2):189-95. PubMed ID: 26631969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1.
    Wang L; Ji XB; Wang LH; Xia ZK; Xie YX; Liu WJ; Qiu JG; Jiang BH; Liu LZ
    Aging (Albany NY); 2021 Nov; 13(21):24037-24049. PubMed ID: 34727092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
    Wu L; Shi B; Huang K; Fan G
    Oncol Rep; 2015 Nov; 34(5):2797-805. PubMed ID: 26352220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexmedetomidine Regulates Proliferation, Apoptosis, Migration, and Invasion in Ovarian Cancer Cells via MiR-155-HIF-1α Axis.
    Zheng L; Jia R; Zhao J
    Med Sci Monit; 2019 Dec; 25():10164-10172. PubMed ID: 31887107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.
    Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS
    Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Variation in MicroRNA-423 Promotes Proliferation, Migration, Invasion, and Chemoresistance in Breast Cancer Cells.
    Morales-Pison S; Jara L; Carrasco V; Gutiérrez-Vera C; Reyes JM; Gonzalez-Hormazabal P; Carreño LJ; Tapia JC; Contreras HR
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways.
    Zhou Y; Feng X; Liu YL; Ye SC; Wang H; Tan WK; Tian T; Qiu YM; Luo HS
    PLoS One; 2013; 8(11):e81203. PubMed ID: 24312276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p.
    Mao Q; Lv M; Li L; Sun Y; Liu S; Shen Y; Liu Z; Luo S
    J Cell Physiol; 2020 Mar; 235(3):2668-2675. PubMed ID: 31490021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).
    Ma Q; Gao Y; Xu P; Li K; Xu X; Gao J; Qi Y; Xu J; Yang Y; Song W; He X; Liu S; Yuan X; Yin W; He Y; Pan W; Wei L; Zhang J
    Biomed Res Int; 2019; 2019():3235021. PubMed ID: 31011573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.